[toc]

- [Summaries](#summaries)
  - [Table 1: Virus Variants and Spike Mutations vs Monoclonal Antibodies](#table.1.virus.variants.and.spike.mutations.vs.monoclonal.antibodies)
  - [Table 2: Virus Variants and Spike Mutations vs Convalescent Plasma](#table.2.virus.variants.and.spike.mutations.vs.convalescent.plasma.and.plasma.from.vaccinated.persons)
  - [Table 3: Virus Variants and Spike Mutations vs Plasma from Vaccinated Persons](/page/susceptibility-data/#table.3.virus.variants.and.spike.mutations.vs.plasma.from.vaccinated.persons)
  - [Figure: Virus Variants and Spike Mutations vs Convalescent Plasma and Plasma from Vaccinated Persons](#figure.virus.variants.and.spike.mutations.vs.convalescent.plasma.and.plasma.from.vaccinated.persons)
- Raw data
  - [Spike variants and mutation combinations / monoclonal antibodies neutralization](https://hivdb.github.io/covid-drdb-reports/resistance-dt.html#spike-variants-and-mutation-combinations-mab-neutralization)
  - [Spike variants and mutation combinations / plasma neutralization](https://hivdb.github.io/covid-drdb-reports/resistance-dt.html#spike-variants-and-mutation-combinations-plasma-neutralization)
  - [Spike mutations _in vitro_ selection](https://hivdb.github.io/covid-drdb-reports/resistance-dt.html#spike-mutation-invitro-selection-cp-and-mab)
- **Individual study details**
  - [Table S1: Neutralizing Sensitivity of Variants to Monoclonal Antibodies](/page/susceptibility-data/mab-variants/)
  - **Table S2: Neutralizing Sensitivity of Spike Mutations to Monoclonal Antibodies**
  - [Table S3: Neutralizing Sensitivity of Variants to Convalescent Plasma](/page/susceptibility-data/cp-variants/)
  - [Table S4: Neutralizing Sensitivity of Spike Mutations to Convalescent Plasma](/page/susceptibility-data/cp-mutations/)
  - [Table S5: Neutralizing Sensitivity of Variants to Plasma from Vaccinated Persons](/page/susceptibility-data/vp-variants/)
  - [Table S6: Neutralizing Sensitivity of Spike Mutations to Plasma from Vaccinated Persons](/page/susceptibility-data/vp-mutations/)
[/toc]

### Table S2: Neutralizing Sensitivity of Spike Mutations to Monoclonal Antibodies

[table]
table_mab_muts
[/table]
